If this formForm is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [  ]o

Indicate by check mark whether the registrantRegistrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large"large accelerated filer,” “accelerated filer”" "accelerated filer," and “smaller"smaller reporting company”company" in Rule 12b-2 of the Exchange Act.  (Check one):

Large Accelerated Filer [  ]                                                                                                                    Accelerated Filer    [  ]

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	¨	Smaller Reporting Company	x
(Do not check if a smaller reporting company)

 Non-Accelerated Filer  [  ]   (Do not check if a smaller reporting company)                   Smaller Reporting Company    [x]

Calculation of Registration Fee

[1]

Title of Each Class of Securities to be Registered		Amount to be Registered (1)				Proposed Maximum Offering Price Per Unit				Proposed Maximum Aggregate Offering Price (2)				Amount of Registration Fee
Common Stock offered by the Company to Premier Venture			2,321,429			$	1.70			$	3,946,429.30
Common Stock held by current shareholders			1,878,571			$	1.70			$	3,193,570.70
TOTAL			4,200,000			$	1.70			$	7,140,000			$	719.00

____________

	(1)	We are registering 2,321,429 shares of our common stock that we may put to Premier Venture Partners, LLC (" Premier Venture ") pursuant to that certain equity purchase agreement (the " Equity Purchase Agreement ") whichwas entered into on June 18, 2015. In the event of stock splits, stock dividends or similar transactions involving the common stock,the number of common shares registered shall, unless otherwise expressly provided, automatically be deemed to cover the additionalsecurities to be offered or issued pursuant to Rule 416 promulgated under the Securities Act of 1933, as amended (the " Securities Act ").In the event that the adjustment provisions of the Equity Purchase Agreement require the registrant to issue more shares than are beingregistered in this Registration Statement, for reasons other than those stated in Rule 416 of the Securities Act, the registrant will file anew registration statement to register those additional shares. We are registering an additional 1,878,571 shares of our common stock which shares are currently outstanding and held by 6 current shareholders (Including 178,571 shares currently held by Premier Ventures, and 1,700,000 shares held by 5 other shareholers) (collectively the "Selling Shareholders")
	(2)	Estimated solely for the purposes of calculating the registration fee under Rule 457.

The Registrant hereby amends this Registration Statementregistration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statementregistration shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statementregistration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

The information in this prospectus is not complete and may be changed. We may not sell these securities until this Registration Statement filed with the Securities and Exchange Commission (the "SEC") is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

PROSPECTUS

LIBERTY VISION, INC.JUBILANT FLAME INTERNATIONAL LTD

4,200,000 Shares of Common Stock

SHARES OF COMMON STOCK$1.70 PER SHARE

1,000,000 Minimum - 10,000,000 Maximum

BeforeThis prospectus relates to the sale of up to 4,200,000 shares of common stock of Jubilant Flame International LTD ("Jubilant Flame", "we", "us", "our" and "our company"), par value $0.001 per share (the "Common Stock"), of which 2,321,429 are issuable to Premier Venture pursuant to the Equity Purchase Agreement, and 1,878,571 are held by current shareholders (including 178,571 shares currently held by Premier Venture). The Equity Purchase Agreement permits us to "put" up to $5,000,000 in shares of our Common Stock to Premier over a period of up to thirty-six (36) months commencing from the effectiveness of this Offering, there has been no public marketRegistration Statement, or until the termination of the Equity Purchase Agreement in accordance with the terms and provisions thereof (the "Open Period"). We will not receive any proceeds from the resale of these shares of Common Stock. However, we will receive proceeds from the sale of securities pursuant to our exercise of the put right offered by Premier Venture. Premier Venture is deemed an underwriter for our common stock.  In

The selling stockholders may offer all or part of the event that we sellshares for resale from time to time through public or private transactions, at leasteither prevailing market prices or at privately negotiated prices. We are paying all of the minimum numberregistration expenses incurred in connection with the registration of the shares in this Offering, of which there is no assurance, we intend to have our shares ofexcept for underwriting discounts, selling commissions, brokerage fees and related expenses.

Our common stock is quoted on the Over-the-Counter Bulletin Board operated by OTC Markets Group, Inc.  There is no assurance that our shares will ever be quoted onOTCBB under the Over-the-Counter Bulletin Board.

We are offering a minimum of 1,000,000 and a maximum of 10,000,000 sharesticker symbol JFIL. On Nov 01, 2015, the closing price of our common stock in a direct public offering, without any involvement of underwriters or broker-dealers.  The offering price is $0.05was $3.00 per share. In the event that 1,000,000 shares are not sold within 180 days of the effective date of our Prospectus, or within an additional 90 days if we choose so, all money received by us will be promptly, returned to you with interest and without deduction of any kind.  The extension of an additional 90 days would result in an offering period of up to 270 days total. Funds will be held in a separate account.  The foregoing account is not an escrow, trust, or similar account.  It is merely a separate interest bearing savings account under our control where we have segregated your funds. Only our officers and Directors will have access to the account. You will not have the right to withdraw your funds during the offering. You will only receive your funds back if we do not raise the minimum amount of the offering within 180 days or, if extended, 270 days. As a result, if we are sued for any reason and a judgment is rendered against us, your subscription could be seized in a garnishment proceeding. If we file a voluntary bankruptcy petition or our creditors file an involuntary bankruptcy petition, our assets will be seized by the bankruptcy trustee, including your subscription, and used to pay our creditors. If that happens, you will lose your investment, even if we fail to raise the minimum amount in this offering.  As a result, you may lose your entire investment notwithstanding the purported minimum offering provisions because the funds are not held in an escrow account and are potentially subject to creditor claims.

Our common stock will be sold on our behalf by Oleg Gabidulin, Vadim Erofeev, Marina Sherbatenko and Ilia Burakov, our Directors. Our Directors will not receive any commissions or proceeds from the offering for selling shares on our behalf. If we raise only the minimum amount of proceeds from this offering we will have limited funds available to build and grow our business. There is no assurance that we will achieve any of additional sales of our equity securities or arrange for debt or other financing for to fund our planned business activities.  We may also rely on loans from our Directors; however, there are no assurances that our Directors will provide us with any additional funds. Currently, we do not have any arrangements for additional financing.  We have no assurance that future financing will be available to us on acceptable terms.  If financing is not available on satisfactory terms, we may be unable to continue, develop, or expand our operations.  Equity financing could result in additional dilution to existing shareholders.

Investing in our common stock involves risks.a high degree of risk. See "Risk Factors" startingbeginning on page 8.8 to read about factors you should consider before investing in shares of our common stock.

Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of the Prospectus.  Any representation to the contrary is a criminal offense.NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

The date of this Prospectusprospectus is ____________.______________ 2016.

Table of Contents

PROSPECTUS SUMMARYProspectus Summary

The following summary highlights selected information contained in this Prospectus.prospectus. This summary does not contain all the information that may be important to you. You should read the more detailed information contained in this Prospectus,prospectus, including but not limited to, the risk factors"Risk Factors" beginning on page 8. In addition, certain statements are forward-looking statements, which involve risks and uncertainties. See “Disclosure Regarding Forward-Looking Statements.”

9. References in this Prospectus to “Liberty Vision”, “Company”, “we”, “our”, or “us” refer to Liberty Vision, Inc.  and its subsidiary, on a consolidated basis, unless otherwise indicated"we," "us," "our," "Jubilant Flame," or the "Company" refers to Jubilant Flame International Ltd. unless the context otherwise requires.indicates another meaning.

Forward-Looking Statements

This Prospectus contains forward-looking statements that involve risks and uncertainties.  We use words such as anticipate, believe, plan, expect, future, intend and similar expressions to identify such forward-looking statements.  You should not place too much reliance on these forward-looking statements.  Our actual results may differ   materially   from those   anticipated in these forward-looking statements for many reasons, including the risks faced by us described in the "Risk Factors" section and elsewhere in this Prospectus.

Our Company

We were formed
Jubilant Flame International Ltd. (the "Company") was incorporated in the State of Nevada, United States of America, on September 29, 2009.2009 under the name Liberty Vision, Inc. The Company changed its name to Jiu Feng Investment Hong Kong Ltd on December 16, 2012. The Company changed its name to Jubilant Flame International Ltd on May 18, 2015. The Company's fiscal year end is February 28. The Company's principal executive offices are located at 3150 Wilshire Blvd Suite 2215, Los Angeles CA 90010, and our telephone number is +76132523673. We are not aprovider blank check company, and have no intentions of services that enable individualsentering into any business combination.

The Company does business in the Medical and small businesses to establish, maintainthe Cosmetic business sectors. In the medical sector the Company conducts Research and evolve an online presence. We offerDevelopment and the planned future marketing of products under license from BioMark Technologies (Asia) Limited, a full rangelimited liability company incorporated in Hong Kong under the Companies Ordinance ("BioMark"). In the cosmetics sector the Company markets cosmetic products under license from Rubyfield Holdings LTD., a company organized under the laws of web services, including custom web design, website usability consulting, website maintenance, web analytics implementation, web marketing services, social and viral marketing campaigns and search engine optimization consulting. We target the individual and small business markets by seeking to provide a “one-stop shop” for establishing and maintaining an online presence. Our services can be purchased independently or as bundled offerings targeted to meet the specific needs of our customers.Hong Kong ("Rubyfield").

SimplifyingBio Medical

On September 30, 2013 the Internet for Small Businesses.Our goal isCompany entered into a License Agreement with BioMark whereby the Company holds a 5 year worldwide license to enable small businesses to outsource their web services needs to us. We guide the customer through the necessary steps to establish their online presence, generate traffic to their websites and increase direct consumer interaction. We provide consulting on a wide variety of issues, from selection of domain name registrars and hosting providers,sell, market, and/or distribute certain products pertaining to the most cost-efficient marketing strategies.health care industry (the "Bio-Medical Products"); and to conduct research and development of BioMark's cancer detection scanning technology. In the event that the research and development of BioMark's cancer detection scanning technology provides marketable technology, the Company shall have the right of first refusal to a license to market, sell and distribute such cancer detection scanning technology. The Company's president, Ms. Yan Li, is also president of, and exercises control over BioMark. 

We generate revenue from sales of web services made directly to small and medium business customers. We acquire customers through referrals and our primary website,www.LibertyVisionOnline.comCosmetics, which outlines our service offerings and showcases our portfolio of work.

5

On January 27, 2011 we have incorporatedNov 16, 2015 the Company entered into a wholly owned (ownership interest – 100%) subsidiary Liberty Vision Media, Inc. Our consolidated financial statements includeDistribution / License Agreement with Rubyfield whereby the accountsCompany is the exclusive independent authorized Master Distributor for all of our subsidiary. All significant intercompany balancesNorth America of certain products pertaining to the cosmetics industry (the "Cosmetics Products"). The Company's president, Ms. Yan Li, is also president of, and transactions have been eliminated on consolidation.exercises control over Rubyfield. 

During the nine months ended November 30, 2015, the Company realized a loss from continuing operations totaling $160,308 We have commenced our operations duringrely upon the year ended February 28, 2010. As of February 28, 2011 we have generated $128.336 in revenues and have incurred $104,717 in operating costs since our inception on September 29, 2009. To date we have relied upon revenues from our operations and sale of our securities in unregistered private placement transactionsand loans from our officers and directors to fund our operations. We are a development stage company with a limited operating history. Accordingly, fordo not expect to generate sufficient revenue to sustain operations during the foreseeable future,next twelve months. Consequently, we will continue to be dependentdepend on revenues from operations and additional financing in order to maintain our operations and continue with our corporate activities. Based on these uncertainties, our independent auditors included additional comments in their report on our financial statements for the years ended February 28, 2015 and 2014, indicating substantial doubt about our ability to continue as a going concern.

On June 18, 2015, we entered into the Equity Purchase Agreement with Premier Venture, a California limited liability company. Pursuant to the terms of the Equity Purchase Agreement, Premier Venture committed to purchase up to $5,000,000 of our common stock during the Open Period. From time to time during the Open Period, we may deliver a put notice (the "Put Notice") to Premier Venture which states the dollar amount that we intend to sell to Premier Venture on a date specified in the Put Notice. The maximum investment amount per notice shall not exceed the lesser of (i) 200% of the average daily trading volume of our common stock on the five trading days prior to the day the Put Notice is received by Premier Venture and (ii) 110% of any previous put amount during the maximum thirty-six (36) month period (however the amount for the preceding (ii) shall never be less than 75,000 shares). The total purchase price to be paid, in connection with each Put Notice, by shall be calculated at The Purchase Price for the Securities for each Put shall be the Put Amount multiplied by seventy percent (70%) of the lowest individual daily volume weighted average price ("VWAP") of the common stock during the five (5) consecutive trading days immediately after the applicable date of the Put Notice, less six hundred dollars ($600.00).

In consideration of the execution and delivery of the Equity Purchase Agreement by Premier Venture, we issued to Premier Venture 178,571 shares of our common stock (the "Initial Commitment Shares").

On the effective date of this Registration Statement, we shall issue to Premier additional commitment shares (the "Additional Commitment Shares") of its common stock representing 2.5% of $5,000,000 divided by the sum equal to the lowest of the daily VWAPs of the commonstock on the three trading days immediately preceding the effective date. The Additional Commitment Shares shall not constitute registerablesecurities and shall not be included in this Registration Statement in accordance with the terms of the Registration Agreement.In connection with the Equity Purchase Agreement, we also entered into a registration rights agreement (the "Registration Rights Agreement") with Premier Venture, pursuant to which we are obligated to file a registration statement with the SEC. We are obligated to use all commercially reasonable efforts to maintain an effective registration statement until termination of the Equity Purchase Agreement.

The 4,200,000 shares to be registered herein represent approximately 38.18% of our common shares issued and outstanding, assuming that the Company will sell all of the 2,321,429 shares offered for sale to Premier Venture.

At an assumed purchase price of $1.19 (representing 70% of $1.70 being the average high and low prices of our common stock as reported on the OTCBB on Oct, 2015), we will be able to receive up to $2,975,000 in gross proceeds, assuming the sale of the entire 2,321,429 shares (2,500,000 shares issuable to Premier Venture, less 178,571 shares which have previously been issued) being registered hereunder pursuant to the Equity Purchase Agreement. Accordingly, we may be required to register additional shares to obtain the balance from the $5,000,000 under the Equity Purchase Agreement.

We are currently authorized to issue 75,000,000 shares of our common stock. Premier Venture has agreed to refrain from holding an amount of shares which would result in Premier Venture owning more than 4.99% of the then-outstanding shares of our common stock at any one time.

There are substantial risks to investors as a result of the issuance of shares of our common stock under the Equity Purchase Agreement. These risks include dilution of stockholders' percentage ownership, significant decline in our stock price and our inability to draw sufficient funds when needed. Premier Venture will periodically purchase our common stock under the Equity Purchase Agreement and will, in turn, sell such shares to investors in the market at the market price. This may cause our stock price to decline, which will require us to issue increasing numbers of common shares to Premier Venture to raise the same amount of funds, as our stock price declines.

Our financial statements contain additional note disclosures describing the circumstances that led to the "going concern" disclosure by our independent auditors. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

This offeringOffering and any investment in our common stock involve a high degree of risk. If our future  revenues will not be sufficientwe are unable to cover our operating costsgenerate significant revenue, we may be obliged to cease business operations due to lack of funds. If we raise only the minimum amount of proceeds from this offering we will have limited funds available to build and grow our business. There is no assurance that we will achieve any of additional sales of our equity securities or arrange for debt or other financing for to fund our planned business activities.  We may also rely on loans from our Directors; however, there are no assurances that our Directors will provide us with any additional funds. Currently, we do not have any arrangements for additional financing.  We have no assurance that future financing will be available to us on acceptable terms.  If financing is not available on satisfactory terms, we may be unable to continue, develop, or expand our operations.  Equity financing could result in additional dilution to existing shareholders.

We face many challenges to continue operations, including our limitedlack of operating history, competition, general economic conditions, etc.  Please review the "Risk Factors" starting on page 8lack of this offering.

Our Directors collectively own 100% of the 3,980,000 outstanding shares of our common stock as of therevenues to date, of this Offering.  If the minimum amount of the shares will be sold, our Directors will own 79.92% of our outstanding common stock.  Accordingly, they will have a significant influence in determining the outcome of all corporate transactions or other matters, including mergers, consolidations and the sale of all or substantially all of our assets.  The interests of our directors may differ from the interests of the other stockholders and thus result in corporate decisions that are disadvantageouslosses we have incurred to other shareholders.

Our principal executive offices are located at2530 Meridian Parkway, Suite 200, Durham, NC and our telephone number is (919) 806-4593.  Our primary website address iswww.LibertyVisionOnline.com.The information on, or that can be accessed through this website is not part of this prospectus.date.

The Offering

Following is a brief summary of this Offering:offering:

Although  forward-looking  statements  in this  Prospectus  reflect  the good  faith judgment of our management, forward-looking statements are inherently subject to known and unknown risks,  business,  economic and other risks and  uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements.  Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Prospectus.  We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Prospectus, other than as may be required by applicable law or regulation.  Readers are urged to carefully review and consider the various disclosures made by us in our Prospectus which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows.  If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.

USE OF PROCEEDS	Our	25% of shares sold				50% of shares sold				75% of shares sold				100% of shares sold
Operational Expenses		$				$				$				$
Legal & Accounting			65,000				65,000				75,000				80,000
Payroll			175,000				220,000				320,000				460,000
Transfer Agent			5,500				6,500				6,500				7,500
Logo development			2,500				2,500				2,500				2,500
Website development & Support			3,500				3,500				3,500				3,500
Warehouse rent, supplies and telephone		,000					50,000				60,000				75,000
Social media marketing			10,000				16,500				18,500				25,000
Online advertising			50,000				50,000				75,000				85,000
Product inventory			45,000				80,000				80,000				150,000
Travel Costs			15,000				15,000				15,000				20,000
R&D			100,000				120,000				200000				250,000
Vehicles							45,000				90,000				135,000
Expansion store fronts and Offices			150,000				300,000				450000				950,000
Misc-reserves											600000				506,500
TOTALS			646,500				904,000				2,000,000				2,762,500

Determination of Offering Price

The offering price to be paid to the Company for shares sold to Premier Venture pursuant to this Registration Statement will be determined by prevailing market prices at the time of any "Put Notice", as defined in the Equity Purchase Agreement, which is 70% of the lowest individual daily VWAP (volume weighted average price) of the Common Stock during the "Pricing Period" (as defined in the Equity Purchase Agreement) less six hundred dollars ($600.00). As our shares are thinly traded, the offering price of $1.70 quoted in this Registration Statement has been estimated by the Company. No investment banker, appraiser, or other independent third party has been consulted concerning the estimation of the offering price for the shares or the fairness of the offering price used for the shares. The actual price paid to the Company for any shares sold to Premier Venture may vary significantly from the estimated offering price. Furthermore, the offering price of the shares of our common stock does not necessarily bear any relationship to our book value, assets, past operating results, financial condition, or any other established criteria of value.

Dilution of the Price per Share

The common stock being registered by the Selling Security Holders will be approximately 38.18% of the then currently issued and outstanding common stock of our company when taking into account the possible future issuance of the remaining 2,321,429 common shares of our company being registered under this Registration Statement.

"Dilution" as used herein represents the difference between the offering price per share of shares offered hereby and the net tangible book value per share of our common stock after completion of the offering. Dilution in the offering is primarily due to the losses previously recognized by our company.

Assuming we sell 100% of the shares being registered for sale by the company at a purchase price of $1.19 (equal to 70% of the $1.70 offering price of our common stock), we will be required to issue an aggregate of 2,321,429 shares of our common stock, with net proceeds to the Company of approximately $2,762,501.

The net tangible book value of our company at February 28, 2015 was $ (499,530). Net tangible book value represents the amount of total tangible assets less total liabilities. Assuming that 100% of the shares offered hereby were purchased by investors (a fact of which there can be no assurance) at a purchase price of $1.19 per share, we would be required to issue an aggregate of 2,321,429 shares of our common stock, with net proceeds to the Company of $2,762,501. The then outstanding 11,000,000 shares of common stock, which would constitute all of the issued and outstanding equity capital of our company, would have a net tangible book value of $2,262,971 (before deducting commissions and offering expenses) or approximately $0.21 per share.

Assuming we sell 50% of the shares being registered for sale by the company at a purchase price of $1.19, we will be required to issue an aggregate of 1,160,715 shares of our common stock, with net proceeds to the Company of approximately $1,381,251.

Assuming we sell 25% of the shares being registered for sale by the company at a purchase price of $1.19, we will be required to issue an aggregate of 580,357 shares of our common stock, with net proceeds to the Company of approximately $690,625.

The dilution associated with the offering and each of the above scenarios is as follows:

							50%				25%
						Shares				Shares
		Offering				Issued				Issued
Offering price		$	1.19			$	1,381,251			$	690,625
Share Price before Offering (per share)		$	-			$	1.70			$	1.70
Net tangible book value after Offering (per share)		$	-			$	0.09			$	0.02
Dilution of ownership percentage to investor			-	%			92	%			98	%

Selling Security Holders

The Company is not making an initial public offering of its common stock. 4,200,000 shares (of which 1,878,571 shares have previously been issued) are being registered pursuant to this Registration Statement. Only the Selling Security Holders listed below may re-sell their shares into the public market as soon as practical after the effective date of this Registration Statement. We are registering, for offer and sale, 4,200,000 shares of common stock issued to the Selling Security Holders, or to be issued to the Premier Venture, as listed below. In the event that fewer than 500,000 shares are issued to Premier Venture, registration of the unissued shares will be terminated.

The following table sets forth information as of the date of the filing of this Registration Statement, with respect to the beneficial ownership of our common stock by the Selling Security Holder. The shares being offered hereby are being registered in accordance with a certain Registration Rights Agreement and Equity Purchase Agreement, each dated December 10, 2014, and the Selling Security Holder may offer all or part of their shares for resale from time to time. However, the Selling Security Holder is under no obligation to sell all or any portion of such shares nor is the Selling Security Holder obligated to sell any shares immediately upon effectiveness of this Registration Statement. The termination date of this Registration Statement is the earlier of (i) thirty-six (36) months from the effectiveness of this Registration Statement, (ii) when the Company receives the full $2,000,000 under the Equity Purchase Agreement, or (iii) as otherwise provided for in the Equity Purchase Agreement.

Name of Selling Security Holder		Shares Owned Prior to this Offering (1)				Percent of Current Outstanding Shares % (2)				Maximum Numbers of Shares Being Offered				Percent of Outstanding Shares if All Registered Shares Issued % (3)
Premier Venture Partners, LLC (4) 4221 Wilshire Blvd., Suite 355, Los Angeles, California 90010			178,571				2.1	%			2,500,000				22.7	%
Guy Vaillant			250,000				2.9	%			250,000				2.3	%
Lise Vaillant			250,000				2.9	%			250,000				2.3	%
Andrew McConnell			200,000				2.3	%			200,000				1.8	%
Robert Ireland			500,000				5.8	%			500,000				4.5	%
Li Yan			500,000				5.8	%			500,000				4.5	%

_________________

(1)	The number and percentage of shares beneficially owned is being made on a self underwritten basis -determined to the best of our knowledge in accordance with a minimum of $50,000 in gross proceeds.  The table below sets forth the use of proceeds if $50,000 (i.e. gross proceedsRules of the minimum offering)SEC and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares as to which the selling security holder has sole or $500,000 (i.e. gross proceedsshared voting or investment power and also any shares which the selling security holder has the right to acquire within 60 days of the maximum offering)date of this Prospectus.
(2)	The percentages are based on 8,678,571 shares of our common stock is sold.issued and outstanding and as at November 30, 2015.
(3)	Our Offering is being conductedThe percentages are based on a best-efforts minimum 1,000,000/ maximum 10,000,000 basis. The offering scenarios presented below are for illustrative purposes only and the actual amount of proceeds, if any, may differ.   Minimum Offering Proceeds (Gross: $50,000) Maximum Offering Proceeds ( Gross: $500,000)   Gross proceeds $ 50,000   $ 500,000   Offering expenses   9,308     9,308   Net proceeds $ 40,692   $ 490,692   The net proceeds will be used as follows:     Minimum Offering Proceeds (Net: $40,692)     Maximum Offering Proceeds ( Net: $490,692)   Liabilities $ 7,481   $ 7,481 Website Optimization Package Development   2,500                         2,500 Ad Serving and Management  Solution Development   30,000                         30,000 Web Developer (Full time), Graphic Designer (Part-time)   -                         120,000 Development of Web Publishing Suite of Services   -                              300,000 General and administrative   711                       30,711 TOTAL $ 40,692   $ 490,692 Total offering expenses are approximately $9,308.  Of the $9,308, the amounts to be paid from the proceeds for expenses of the offering are: $3,250 for accounting fees; $800 for filing fees; $4,200 for legal fees; $58 for registration fee; and $1,000 for transfer agent fees. We will use the rest of the funds (net of offering expenses) 14  for paying off our current liabilities, hiring new personnel and implementation of our business plan. In the future, in addition to equity financing, we may rely on loans from our Directors and officers to continue our operations; however, there are no assurances that our Directors will provide us with any additional funds.  Currently, we do not have any arrangements for additional financing.  If we are not able to obtain needed financing and generate sufficient revenue from operations, we may have to cease operations. DETERMINATION OF OFFERING PRICE The offering price of $0.0511,000,000 shares of our common stock has been arbitrarily determinedin order for usoutstanding if all 2,321,429 shares are issued to raise up to a totalPremier Venture.
(4)	The control person of $500,000 in this Offering and bears no relationship to any objective criterion of value. The price does not bear any relationship to our assets, book value, historical earnings or net worth. In determining the offering price, management considered such factors as the prospects, if any, for similar companies, anticipated results of operations, present financial resources and the likelihood of acceptance of this offering. In addition we took into consideration the most recent shares for debt settlement with our directors and officers at a deemed price of $0.05 per share. No valuation or appraisal has been prepared for our business. We cannot assure you that a public market for our securities will develop or continue or that the securities will ever trade at a price higher than the offering price.Premier Venture Partners, LLC is Jeffrey Maller

Except as otherwise noted in the above list, the named party beneficially owns and has sole voting and investment power over all the shares or rights to the shares. The numbers in this table assume that the Selling Security Holder will not sell shares not being offered in this Prospectus or will purchase additional shares, and assumes that all the shares being registered will be sold.

The Selling Security Holders have not had a material relationship with us other than as a security holder at any time within the past three years, or has ever been one of our officers or directors or an officer or director of our predecessors or affiliates, except as follows: Robert Ireland is secretary and treasurer, and Li Yan is our president and director.

The Selling Security Holder is not a broker-dealer or affiliate of a broker-dealer.

Plan of Distribution

We are registering 2,500,000 shares in accordance with the Equity Purchase Agreement. The 2,500,000 shares include 178,571 shares previously issued in accordance with the Equity Purchase Agreement. The actual price of the remaining 2,321,429 shares which may be issued in accordance with the Equity Purchase Agreement will be 70% of the lowest reported trade of our common stock during the "Put Period" as defined in the Equity Purchase Agreement. We will receive 100% any proceeds from the future sale of registered shares to Premier Venture, but will not receive any proceeds upon the re-sale of any of the registered shares by the Selling Security Holders, nor will we receive any proceeds upon the re-sale of the 178,571 shares previously issued in accordance with the Equity Purchase Agreement.

In the event that the Selling Security Holders enter into an agreement, after the effective date of this Registration Statement, to sell their shares through a broker-dealer that acts as an underwriter, we will file a post-effective amendment to this Registration Statement and file the agreement as an exhibit to the amended Registration Statement. The amendment will identify the underwriter, provide the required information on the plan of distribution and revise the appropriate disclosures in the Registration Statement.

Any underwriter, dealer, or agent who participates in the distribution of the securities registered in this Registration Statement is an "underwriter" under the Securities Act. Further, any discounts, commissions, or concessions received by any such underwriter, dealer or agent will be deemed to be underwriting discounts and commissions under the Securities Act. In the event an "underwriter" will assist in the sale of the shares, we will disclose:

DILUTION OF THE PRICE PER SHARE

In addition and without limiting the foregoing, the Selling Security Holder will be subject to applicable provisions, rules and regulations under the Exchange Act with regard to security transactions during the period of time when this Registration Statement is effective.

We will pay all expenses incidental to the registration of the shares (including registration pursuant to the securities laws of certain states) other than commissions, expenses, reimbursements and discounts of underwriters, dealers or agents, if any.

Any purchasers of our securities should be aware that any market that develops in our stock would be subject to the penny stock restrictions.

Section 15(g) of the Exchange Act

Section 15(g) of the Exchange Act will cover our shares and Rules 15g-1 through 15g-6 promulgated thereunder. Securities regulations impose additional sales practice requirements on broker-dealers who sell our securities to persons other than established customers and accredited investors (generally institutions with assets in excess of $5,000,000 or individuals with net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouses).

Rule 15g-1 exempts a number of specific transactions from the scope of the penny stock rules (but is not applicable to us).

Rule 15g-2 declares unlawful broker-dealer transactions in penny stocks unless the broker-dealer has first provided to the customer a standardized disclosure document.

Rule 15g-3 provides that it is unlawful for a broker-dealer to engage in a penny stock transaction unless the broker-dealer first discloses and subsequently confirms to the customer current quotation prices or similar market information concerning the penny stock in question.

Rule 15g-4 prohibits broker-dealers from completing penny stock transactions for a customer unless the broker-dealer first discloses to the customer the amount of compensation or other remuneration received as a result of the penny stock transaction.

Rule 15g-5 requires that a broker-dealer executing a penny stock transaction, other than one exempt under Rule 15g-1, disclose to its customer, at the time of or prior to the transaction, information about the sales persons compensation.

Rule 15g-6 requires broker-dealers selling penny stocks to provide their customers with monthly account statements.

Rule 15g-9 requires broker/dealers to approve the transaction for the customer's account; obtain a written agreement from the customer setting forth the identity and quantity of the stock being purchased; obtain from the customer information regarding his investment experience; make a determination that the investment is suitable for the investor; deliver to the customer a written statement for the basis for the suitability determination; notify the customer of his rights and remedies in cases of fraud in penny stock transactions; and, the FINRA's toll free telephone number and the central number of the North American Administrators Association, for information on the disciplinary history of broker/dealers and their associated persons.

Rule 3a51-1 of the Exchange Act establishes the definition of a "penny stock," for purposes relevant to us, as any equity security that has a minimum bid price of less than $4.00 per share or with an exercise price of less than $4.00 per share, subject to a limited number of exceptions. It is likely that our shares will be considered to be penny stocks for the immediately near future. For any transaction involving a penny stock, unless exempt, the penny stock rules require that a broker or dealer approve a person's account for transactions in penny stocks and the broker or dealer receive from the investor a written agreement to the transaction setting forth the identity and quantity of the penny stock to be purchased.

In order to approve a person's account for transactions in penny stocks, the broker or dealer must obtain financial information and investment experience and objectives of the person and make a reasonable determination that the transactions in penny stocks are suitable for that person and that that person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prepared by the SEC relating to the penny stock market, which, in highlight form, sets forth:

	·	The basis on which the broker or dealer made the suitability determination, and
	·	That the broker or dealer received a signed, written agreement from the investor prior to the transaction.

Disclosure also has to be made about the risks of investing in penny stock in both public offerings and in secondary trading and commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Additionally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

Many brokers have decided not to trade penny stocks because of the requirements of the penny stock rules and, as a result, the number of broker-dealers willing to act as market makers in such securities is limited. If we remain subject to the penny stock rules for any significant period, which is likely, it could have an adverse effect on the market, if any, for our securities. If our securities are subject to the penny stock rules, investors will find it difficult to dispose of our securities.

Section 15(g) of the Exchange Act

Our shares are "penny stocks" covered by Section 15(g) of the Securities Exchange Act of 1934, as amended, and Rules 15g-1 through 15g-6 promulgated thereunder. Our shares are covered by Section 15(g) of the Exchange Act, and Rules 15g-1 through 15g-6 promulgated thereunder.  They impose additional sales practice requirements on broker-dealers who sell our securities to persons other than established customers and accredited investors (generally institutions with assets in excess of $5,000,000 or individuals with net worth in excess of $1,000,000 or annual income exceeding $200,000 or $300,000 jointly with their spouses). For transactions covered by the Rule, the broker-dealer must make a special suitability determination for the purchase and have received the purchaser's written agreement to the transaction prior to the sale. Consequently, the Rule may affect the ability of broker-dealers to sell our securities and also may affect your ability to resell your shares.

Section 15(g) also imposes additional sales practice requirements on broker-dealers who sell penny securities. These rules require a one-page summary of certain essential items. The items include the risk of investing in penny stocks in both public offerings and secondary marketing; terms important to an understanding of the function of the penny stock market, such as "bid" and "offer" quotes, a dealers "spread" and broker-dealer compensation; the broker-dealers duties to its customers, including the disclosures required by any other penny stock disclosure rules; the customers rights and remedies in causes of fraud in penny stock transactions; and, FINRA's toll free telephone number and the central number of the North American Administrators Association, for information on the disciplinary history of broker-dealers and their associated persons.

Rule 15g-1 exempts a number of specific transactions from the scope of the penny stock rules.

Rule 15g-2 declares unlawful broker-dealer transactions in penny stocks unless the broker-dealer has first provided to the customer a standardized disclosure document.

Rule 15g-3 provides that it is unlawful for a broker-dealer to engage in a penny stock transaction unless the broker-dealer first discloses and subsequently confirms to the customer current quotation prices or similar market information concerning the penny stock in question.

Rule 15g-4 prohibits broker-dealers from completing penny stock transactions for a customer unless the broker-dealer first discloses to the customer the amount of compensation or other remuneration received as a result of the penny stock transaction.

18

Rule 15g-5 requires that a broker-dealer executing a penny stock transaction, other than one exempt under Rule 15g-1, disclose to its customer, at the time of or prior to the transaction, information about the sales persons compensation.

Rule 15g-6 requires broker-dealers selling penny stocks to provide their customers with monthly account statements.

The foregoing rules apply to broker-dealers. They do not apply to us in any manner whatsoever. The application of the penny stock rules may affect your ability to resell your shares because many brokers are unwilling to buy, sell or trade penny stocks as a result of the additional sales practices imposed upon them.

Regulation M

We are subject to Regulation M of the Securities Exchange Act of 1934. Regulation M governs activities of underwriters, issuers, selling security holders, and others in connection with offerings of securities. Regulation M prohibits distribution participants and their affiliated purchasers from bidding for purchasing or attempting to induce any person to bid for or purchase the securities being distributed. Our president and director, who will sell the shares, is aware that he is required to comply with the provisions of Regulation M, promulgated under the Securities and Exchange Act of 1934, as amended.

Description of SecuritiesCommon Stock

The following description of our capital stock and provisions of our Articles of Incorporation, and Bylaws is only a summary. You should also refer to our Articles of Incorporation, a copy of which is incorporated by reference as an exhibit to the registration statement of which this prospectus is a part, and our Bylaws, a copy of which is incorporated by reference as an exhibit to the registration statement of which this prospectus is a part.

We are authorized to issue up to 75,000,000 of our Common Shares, Par Value $0.001 per share. Each holder of common stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. We have not provided for cumulative voting for the election of directors in our Articles of Incorporation. This means that the holders of a majority of the shares voted can elect all of the directors then standing for election. Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our common stock are entitled to receive dividends out of assets legally available at the times and in the amounts that our board of directors may determine from time to time.

Holders of common stock have no preemptive subscription, redemption or conversion rights, or other subscription rights. Upon our liquidation, dissolution, or winding-up, the holders of common stock are entitled to share in all assets remaining after payment of all liabilities and the liquidation preferences of any outstanding preferred stock. Each outstanding share of common stock is, and all shares of common stock to be issued in this Offering, when they are paid for will be, fully paid and non-assessable.

As of the date of this prospectus, we have not paid any cash dividends to stockholders. The declaration of any future cash dividend will be at the discretion of our board of directors and will depend upon our earnings, if any, our capital requirements and financial position, our general economic conditions, and other pertinent conditions. It is our present intention not to pay any cash dividends in the foreseeable future, but rather to reinvest earnings, if any, in our business operations.

Anti-Takeover Provisions

Our bylaws provide that one or more or all the Directors of the Corporation may be removed with or without cause at any time by a vote of two-thirds of the shareholders entitled to vote thereon, at a special meeting of the shareholders called for that purpose. The two-thirds requirement is intended to protect shareholder interests by providing the Board of Directors a means to attempt to deny coercive takeover attempts or to negotiate with a potential acquirer in order to obtain more favorable terms. However, such provision could discourage, delay or prevent an unsolicited merger, acquisition or other change in control of our company that some shareholders might believe to be in their best interests or in which shareholders might receive a premium for their common stock over the prevailing market price. This provision could also discourage proxy contests for control of the Company.

Interest of Named Experts and Counsel

No expert or counsel named in this prospectus as having prepared or certified any part of this prospectus or having given an opinion upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering of the common stock was employed for such purpose on a contingency basis, or had, or is to receive, in connection with this Offering, a substantial interest, direct or indirect, in us or any of our parents or subsidiaries, if any, nor was any such person connected with us or any of our parents or subsidiaries as a promoter, managing or principal underwriter, voting trustee, director, officer, or employee.

Legal Matters

The validity of the common stock offered hereby will be passed upon by the law firm of Befumo & Schaeffer, PLLC, PO Box 65873, Washington, DC 20035 .

Experts

The financial statements appearing in this prospectus and registration statement on Form S-1 have been audited by Cutler & Co., LLC, an independent registered public accounting firm, as set forth in their report thereon appearing elsewhere in this prospectus and in the registration statement on Form S-1, and such report is included in reliance upon such report given upon the authority of such firm as experts in accounting and auditing.

Cautionary Note Regarding Forward-Looking Statements

This prospectus contains forward-looking statements that involve assumptions, and describe our future plans, strategies, and expectations. Such statements are generally identifiable by use of the words "may," "will," "should," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. These statements are expressed in good faith and based upon a reasonable basis when made, but there can be no assurance that these expectations will be achieved or accomplished.

Such forward-looking statements include statements regarding, among other things, (a) the potential markets for our products, our potential profitability, and cash flows (b) our growth strategies, (c) anticipated trends in our industry, (d) our future financing plans and (e) our anticipated needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under "Management's Plan of Operation" and "Description of Our Business and Properties," as well as in this prospectus generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the risks outlined under "Risk Factors" and matters described in this prospectus generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. In addition to the information expressly required to be included in this filing, we have provided in this registration statement such further material information as may be necessary to ensure that the required statements, in light of the circumstances under which they are made, are not misleading.

Although forward-looking statements in this report reflect the good faith judgment of our management, forward-looking statements are inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, other than as may be required by applicable law or regulation. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.

Information about the Company

Description of Business

Jubilant Flame International Ltd. (the "Company") was incorporated in the State of Nevada, United States of America, on September 29, 2009 under the name Liberty Vision, Inc. On December 16, 2012, the Company changed its name to Jiu Feng Investment Hong Kong Ltd. On July 24, 2013, the Company changed its business sector to the medical sector. On September 30, 2013, the Company entered into a world-wide five year licensing agreement with BioMark whereby the Company holds a 5 year worldwide license to sell, market and, or, distribute Bio-medical Products, and to conduct research and development of BioMark's cancer detection scanning technology. In the event that the research and development of BioMark's cancer detection scanning technology provides marketable technology, the Company shall have the right of first refusal to a license to market, sell and distribute such cancer detection scanning technology. The Company's president, Ms. Yan Li, is also president of BioMark. On May 18, 2015, the Company changed its name to Jubilant Flame International, Ltd. On November 16, 2015 Jubilant Flame International entered into a licensing agreement with Reparo to distribute all of their products, mainly cosmetics, in the North American market. Ms. Yan Li our president also exercises control and is the CEO of Reparo.

Jubilant Flame International Ltd is a distributor of cosmetics and medical supplies to industrial clients. The Company will be a distributor for Reparo and BioMark China. Our goal is to reduce the expenses associated with processing Redistribution orders, by providing unified services and support throughout the supply chain from initial order through final delivery. By collecting a comprehensive group of services under one umbrella, We offer distributors and their customers more options for product selection, pricing and delivery without the need to work with different vendor organizations or multiple contacts. This greatly simplifies the process for customers and allows streamlining of processes for reduced shipping and warehousing costs.

Jubilant Flame International Ltd will sell its products and services to the wholesale and retail l cosmetic industry, general retailers, SPA's, Beauty Salons, shopping networks, and other companies that sell cosmetic supplies, as well as our own store fronts.

The Company's president, Ms. Yan Li, has existing relationships with customers and distributors interested in the Company's products, including 2 distributors that the president has done business with in the past 6 months,   10 customers that have verbally committed to do business with the Company, and 18 potential customers that have expressed a willingness to purchase products from the Company upon initial rollout of our product line. The Company has a list of approximately 1000 potential customers that are target prospects. Jubilant Flame International Ltd is currently developing an aggressive e-commerce campaign to target these industries across the country and bordering countries. 

ReparoProducts:

Rule 15g-9 requires broker-dealers

Product	Photo	Function
Reparo K II-Gen Patch		Contains ultra purified fermented collagen and Vitamin C derivatives to approvedhelp with collagen synthesis and improve pigmentation and skin damage caused by stretch marks. It is also designed to induce the transactionregeneration of collagen to improve the appearance of stretch marks.
Reparo K II-Gen Facial Mask		This highly-enriched nutritive mask contains 5% collagen which is the main component of the dermis of the skin. This product is designed to provide nutritive, elastic and moisturizing skin care after a single use.

Reparo K II-Gen Essence		This moisturizing and antioxidant blend of 25% highly enriched undiluted collagen solution and Vitamin E derivatives is designed to improve skin aging and pigmentation, and comprehensively enhance the elasticity of skin.
Reparo CoCo Soft Peeling Essence		This Peeling Essence is designed to provide moist, clean and clear skin by removing the rough, thick dead skin without harming the underlying layer. When applied to the skin, the cellulose turns into scrub particles together with other ingredients including extracts of white willow bark and multi-fruit BSC/AHA.
Reparo Chojeong 88 Sparkling Water Gel		The natural ingredients including platycodon grandiflorum root extract, aloe vera etc in Chojeong Sparkling Water are designed to provide nutrition, moisture and a protective mask for the customer's account; obtainskin.

Reparo CoCo Cleansing Water		Coconut based coco cleansing water is designed to cleanse the skin without washing. Containing coconut extract, a written agreement fromnatural surfactant, it is designed to help provide moisture to the customer setting forthskin, clean blackheads and thoroughly clean makeup. Natural ingredients form a moisturizing membrane.
Collagen Wash-off Cleansing Foam		This cleansing product is designed to remove make-up and waste in pores.
Extra Solution Essential Skin-lotion		A 3-in-one product (toner + lotion + essence) that contains 10% hydrolysis collagen designed to supply nutrition and moisture to the identityskin.
Arbutin Whitening Cream		A cream designed to restrain the production of Melanin and quantityremove Melanin to achieve a whitening effect. It is also designed to strengthen elasticity and supply nutrition to generate clean and healthy skin.

Blemish Balm		A blemish balm designed to improve the appearance of wrinkles, and promote skin re-generation and cover skin defects.
Reprise in Tripeptide Essence Cream		A nutritional cream that is designed to tighten the skin by strengthening elasticity and quickly removing wrinkles.
Reprise in Tripeptide Skin Essence		A toner containing collagen and peptide that is designed to revitalize and moisturize the skin, reduce wrinkles and leave the skin feeling rich and soft.
Reprise in Tripeptide Eye Cream		The effective ingredients of hexa-peptide GANA (ingredients of BOTOXÒ[1]) are designed to help with absorption in the dermis, to work on deep wrinkles, to increase the density of the stock being purchased; obtain fromelastic cells and strengthen the customer information regarding his investment experience; make a determination thatthin skin around the investmenteyes. This product is suitable fordesigned to provide excellent results in tightening the investor; deliverskin around the eyes and improving wrinkles.
Cell Pure 2500 Ampoule		Containing 25% super-pure low molecular collagen, this highly concentrated Ampoule is designed to supply moisture and nutrition to rough and dry skin, and to leave the customer a written statement for the basis for the suitability determination; notify the customer of his rightsskin elastic and remedies in cases of fraud in penny stock transactions; and, the NASD’s toll free telephone number and the central number of the North American Administrators Association, for information on the disciplinary history of broker-dealers and their associated persons.healthy.

^{_____________________}

^[1] BOTOXÒ is a registered trademark of Allergan, Inc

The application of the penny stock rules may affect your ability to resell your shares.

29

Rubyfield Products Continued

Reparo K II-Gen Patch

Description

The Reparo K-II Gen Patch is designed to help prevent and improve the appearance of stretch marks due to pregnancy (before and after) or a sudden increase or decrease in body weight. It contains a combination of ultra purified fermented collagen and Vitamin C derivatives to supply moisture and nutrition, and improve the elasticity and softness of loose skin. While individual differences in the capacity of the skin regeneration cycle and synthesis of collagen can have a great effect on the treatment, Reparo K-II Gen Patch uses state of the art technology to combine ultra-purified fermented collagen with a superior delivery method to yield results superior to the competition.

What are Stretch Marks?

Stretch marks are a form of scarring on the skin with an off-color hue. They are caused by tearing of the dermis, which over time may diminish, but will not disappear completely.

Stretch marks are often the result of the rapid stretching of the skin associated with rapid growth or rapid weight changes.

Offering Period and Expiration Date

30

Causes of Stretch Marks

This Offering will start on

Increased body weight	Stretch marks appear in different areas, concentrated in the date of this Prospectuslower leg and continue for a period of upthigh areas
Pregnancy and childbirth	Stretch marks appear from the lower abdomen to 180 days,the navel
Weight loss	More red stretch marks than white
Steroid hormone	Compared to normal stretch marks, these are different in shape and an additional 90 days, if so elected by our Board of Directors. The extension of an additional 90 days would resultposition, and can vary in an offering period of up to 270 days total.appearance
Physical problems	Majority have genetic causes

Treatment

Most anti-aging creams just include moisturizing ingredients. Our products also contain specific anti-aging ingredients, such as ultra purified fermented collagen and hexa-peptide GANA (ingredients found in BotoxÒ) that promote absorption in the deeper layers (dermis) to reduce deep wrinkles by increasing the density and elasticity of cells and rejuvenating the structure of thin skin around the eyes and other areas, resulting in firmer and younger looking skin.

Epidermal growth factor stimulates cell renewal and collagen production in the skin as well as strengthens skin elasticity and structure. The discovery of epidermal growth factor won Dr. Stanley Cohen and Rita Levi-Montalcini a Nobel Prize in Physiology and Medicine in 1986. In various research by Dr. Stanley Cohen and Nobel Prize submission, epidermal growth factor has been shown to reduce fine lines, wrinkles and sagging. It also has healing (wounds and burns) and anti-inflammatory properties when applied to skin.

According to Journal of Controlled Release, April 2007, pages 169–176; Journal of Burn Care and Rehabilitation, March–April 2002, pages 116–125; and Journal of Dermatologic Surgery and Oncology, July 1992, pages 604–606 collagen is essential for the recovery and growth of damaged dermis.

Reparo K II-Gen Patch is designed to:

Procedures

	·	Supply new collagen for Subscribingrepair into the separated collagen of the dermis layer.
	·	Supply vitamin C derivatives and collagen to improve the synthesis of collagen in the body leading to faster results.

Function of Collagen

	Epidermis layer
	Dermis or Corium layer [Mainly consists of Collagen to maintain skin elasticity and gloss]
	Hypodermis layer

[Highly Moisturizing]		[Longer Protection]
Increased Ability to Protect		Moisture % of the Epidermis

The first graph outlines the % of moisture (Y Axis) after using Collagen and out KII –Gen Collagen increases the moisture in the skin significantly. The second graph shows the KII-Gen Collagen lasts for almost 5 weeks the % of moisture (Y axis) is maintained over a number of weeks (X axis). Based on in-house testing of the product.

If you decide to subscribe for any shares in this Offering, you must: (i) execute and deliver a subscription agreement; and (ii) deliver a check, money order or certified funds to us for acceptance or rejection.  All checks, money orders or certified funds for subscriptions must be made payable to Liberty Vision, Inc.

32

K II-Gen Patch Benefits

1. Different Raw Materials

Collagen	● Stable
	● Low Molecular Weight
	● Mix of Amino Acids

Right to Reject SubscriptionsAscorbic Acid We have the right to accept or reject subscriptions in whole or in part, for any reason or for no reason.  All monies from rejected subscriptions will be returned immediately by us to the subscriber, without interest or deductions.  Subscriptions for securities will be accepted or rejected within 48 hours after we receive them. MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONGlucoside	We are a development stage corporation with limited operations and limited revenues from our business operations.  To meet our needs for cash required for● Lightens the implementationColor of our business plan we are attempting to raise money from this offering. Stretch Marks	If we raise the minimum amount through this offering, we will be able to achieve short term goals of our business plan and to continue operations and remain in business for the next 12 months.  If we are unable to generate revenues  for any reason, or if we are unable to make a reasonable profit, we may have to cease operations.  At the present time, we have not made any arrangements to raise additional cash, other than through this offering. If we need additional cash and cannot raise it, we will either have to suspend implementation of our business plan until we do raise the cash, or cease operations entirely if revenue from operations will not be sufficient to cover our operating costs.
	19
	If we raise the maximum amount, we believe we can implement our short term and long-term business plan and achieve profitable operations, however, we cannot guarantee that proceeds from this offering will be sufficient for us to continue as going concern for the next five years.  If we raise less than the maximum amount and we need more money, we will have to revert to obtaining additional money through a second public offering, a private placement of securities, or loans.  Other than as described in this paragraph, we have no other financing plans.	Limited Operating History; Need for Additional Capital There is limited historical financial information about us upon which to base an evaluation of our performance.  We are in the development stage of operations and cannot guarantee that we will be successful in our business operations.  Our business is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources and possible cost overruns, such as increases in advertizing and marketing costs, increases in administration expenditures associated with daily operations, increases in accounting and audit fees, increases in legal fees related to filings and regulatory compliance.     We anticipate relying on equity sales of our common stock in order to continue to fund implementation of our business plan.  Issuances of additional shares will result in dilution to our existing stockholders.  There is no assurance that we will achieve any of additional sales of our equity securities or arrange for debt or other financing for to fund our planned business activities.  We may also rely on loans from our Directors; however, there are no assurances that our Directors will provide us with any additional funds. Currently, we do not have any arrangements for additional financing.  We have no assurance that future financing will be available to us on acceptable terms.  If financing is not available on satisfactory terms, we may be unable to continue, develop, or expand our operations.  Equity financing could result in additional dilution to existing shareholders. Results of Operations From Inception on September 29, 2009 through February 28, 2011. Our results of operations, as reported in our consolidated financial statements, incorporate results of operations of our wholly owned Canadian subsidiary. All significant intercompany balances and transactions have been eliminated on consolidation. We were formed on September 29, 2009, and commenced our operations during the year ended February 28, 2010. Liberty Vision, Inc. is a provider of services that enable individuals and small businesses to establish, maintain and evolve an online presence.

● Moisturizes

● Provides Nutrition

● Stabilizes

Other Benefits

2. Different Delivery Method

During the period from September 29, 2009 (inception), through February 28, 2011, we have generated $128,336 in revenues from sales and incurred $104,717 in operating costs since inception. We generate revenue from sales of our services such as website development, web marketing, social media marketing and search engine optimization consulting. Our cost of revenues consisted of salaries and wages, professional fees, office rent, officers’ compensation expense, and other general and administrative expenses.

As of February 28, 2011, we incurred $104,717 in operating costs including $44,000 for consulting fees; $20,000 for management fees, $20,175 for salaries and wages, $6,493 for rent, $855 for organization costs and $13,194 for other general and administrative costs.Patch Delivery System 20 We have hired consultants in the areas of bookkeeping and accounting.  We have retained an attorney in relation to this Registration Statement, and an auditor to audit our financial statements.  As of the date of this prospectus we have two full-time employees. We plan to hire additional personnel, subject to financing and our cash flow from operations, within twelve months from the effective date of our registration statement. Since inception, we have sold 2,700,000 shares of common stock at $0.001 per share to our Directors for total proceeds of $2,700 and issued 1,280,000 restricted shares of common stock in the capital of the Company at a deemed price of $0.05 per share to settle the amounts owed to the Company’s President and Chief Financial Officer for consulting and management services. Liquidity and Capital Resources As of February 28, 2011, our total assets of $100,843 consisted of cash of $84,665, accounts receivable of $12,660 and computer equipment of $3,518 and our total liabilities were $10,524 for a total working capital of $86,801.  During the period from September 29, 2009 (inception) through February 28, 2011, we have financed our operations through the issuance of 2,700,000 shares of common stock at $0.001 per share to our Directors for total proceeds of $2,700, issuance of 1,280,000 shares of common stock at a deemed price of $0.05 per share for consulting and management services and revenues of $128,336. As of February 28, 2011, we had cash of $84,665 and accounts receivable of $12,660.  We believe that we need approximately an additional $50,000 (gross) to implement our short-term business plan and meet our working capital requirements over the next 12 months.  Our intention is to obtain this money through this offering. We intend to use the proceeds from this offering to finance our ongoing operations and implementation of our short-term (12 months) business plan (see Plan of Operations, page 26). As of the date of this Registration Statement we do not have any other arrangements of sources of financing beside anticipated proceeds from this offering and proceeds from future sales. We anticipate future capital requirements for financing of our ongoing operations to be approximately $100,000 per year. In addition we will require approximately $330,000 over the five-year period for development and introduction of the new products. To date, our cash flow requirements have been primarily met by cash generated from revenues and equity financings.   Management expects to keep operating costs to a minimum until cash is available through financing or operating activities. Management plans to continue to seek, in addition to equity financing, other sources of financing (e.g. bank loan, line of credit, shareholder loan) on favorable terms; however, there are no assurances that any such financing can be obtained on favorable terms, if at all.   If we are unable to generate profits sufficient to cover our operating costs or unable to obtain additional funds for our working capital needs, we may need to cease or curtail operations.  Furthermore, there is no assurance the net proceeds from any successful financing arrangement will be sufficient to cover cash requirements during the initial stages of the Company’s operations. DESCRIPTION OF OUR BUSINESS AND PROPERTIES You should rely only on the information contained in this Prospectus or any supplement hereto.  We have not authorized anyone to provide you with different information.  If anyone provides you with different information, you should not rely on it.  We are not making an offer to sell the shares in any jurisdiction where the offer is not permitted.  You should not assume that the information contained in this Prospectus is accurate as of any date other than the date on the front cover of this Prospectus regardless of the date of delivery of this Prospectus or any supplement hereto, or the sale of the shares.  Our business, financial condition, results of operations and prospects may have changed since that date. 21 We were formed on September 29, 2009. Liberty Vision, Inc. is aprovider of services that enable individuals and small businesses to establish, maintain and evolve an online presence. We offer a full range of web services, including custom web design, website usability consulting, website maintenance, web analytics implementation, web marketing services, social and viral marketing campaigns and search engine optimization consulting. On January 27, 2011 we have incorporated a wholly owned (ownership interest – 100%) subsidiary Liberty Vision Media, Inc. Our consolidated financial statements include the accounts of our subsidiary. All significant intercompany balances and transactions have been eliminated on consolidation. References in this Prospectus to “Liberty Vision” refer to Liberty Vision, Inc. and its subsidiary, on a consolidated basis, unless otherwise indicated or the context otherwise requires. Web Design and Online Marketing Industry Web Design The internet has become the primary source for information for many people as well as a way to purchase goods and services, socialize and access the most up to date news. While most large corporations already use the internet to market and sell to customers around the world, many small and new businesses have not capitalized on the global reach and ease of communication a website provides.In today’s world it is essential for companies who want to attract new consumers to have a website that is professional and informative. Many new businesses and small businesses that do not yet have an online presence are using web developers to help design and launch their websites. With a large number of web development companies, both large and small, and the demand for professionally designed websites, the web development industry is highly competitive. There are many reasons for a business to invest in developing a website. Some advantages of having a website include: ·Businesses with a website are open to customers for business 24 hours a day and potential customers in different time zones do not have to conform to regular office hours in order to purchase products or find more information about a business. Online forms can be used to allow potential customers to request quotes or other information, without the cost of a long distance call. ·A website is also much easier and cost effective to update than any printed material, which allows companies to provide consumers with more comprehensive and up to date information. ·Another advantage of having an online presence is the ability to sell your products through an online store. This allows a potential customer to browse through a company’s products and purchase them from the comfort of their homes. It also allows customers to purchase products that are not available in their local stores. ·A website can also be used as an effective recruiting tool. Many businesses areposting job opportunitieson their websites as well as descriptions about the company’s benefits and culture. Online Marketing Online marketing is relatively inexpensive when compared to traditional advertising. Companies can reach a wide audience for a small fraction of a traditional advertising budget. Many consumers now use the internet as one of the primary sources to gather information about companies and purchase goods and services.  Online marketing allows companies to target those consumers and bring them directly to their website with a fairly low marketing budget. 22 A big advantage of online marketing is the ability to measure statistics easily and relatively inexpensively. Nearly all aspects of an Internet marketing campaign can be tracked, measured, and tested. Companies who use online marketing can use a variety of methods to track the results of their campaigns through the use of such tracking devices as web analytics. Therefore, marketers can determine which messages or offerings are more appealing to the audience. The results of campaigns can be measured and tracked immediately because online marketing initiatives usually require users to click on an advertisement, visit a website, and perform a targeted action. Such measurement cannot be achieved through billboard advertising, where an individual may be interested but has to take additional steps, such as visiting a store or researching online to obtain more information or purchase the product or service being advertised. Due to the effectiveness of online advertising and the relatively low cost, many companies are now using online marketing alongside traditional marketing. For small businesses that do not have a large marketing budget, online marketing is sometimes the only way they can advertise their business to consumers. Online Marketing tools include: -Paid Search Advertising. Paid search advertising refers to search engine advertising such as Google AdWords (Yahoo and MSN have similar paid search programs available). With paid search advertising, companies only pay each time someone clicks from their ad on the search engine (e.g. Google) through to their website. The main benefit of this type of online advertising is an immediate increase in targeted website traffic and potential new clients. -Email Marketing. Email marketing is an integral part of an effective online marketing strategy. While being targeted, measurable and effective, and at half the cost of traditional direct marketing efforts, e-marketing campaigns and newsletters have provided a form of communication that many companies are now adding to their marketing initiatives. -Social Media Marketing. Social Media Marketing is a popular web marketing method. With high traffic sites like Facebook, YouTube and Twitter available to help businesses, smart business owners are investing in this highly profitable niche to not only drive traffic to their sites, but to get people talking about their company and its products. -Blogging.Blogging is another popular online marketing tool that allows companies to write about new developments in their business in an informal and relatable way as well as constantly add new content to their websites and increase their search engine optimization. Competition Competition in the web development and online advertising industry is intense and highly fragmented. Our competition is any company that provides one or more of our company’s core service offerings. Our competition includes Advertising Firms, Public Relations Companies, Web Design Companies, Graphic Design Companies, and Search Engine Optimization Firms.  Our competitors range in size from small, local independent firms and individuals to very large conglomerates. Such fragmentation can mean that a small business owner can employ more than one web services provider to get a needed mix of web design and online marketing services for their desired budget. The web services industry is always evolving with thousands of new competitors entering the market every year. It is becoming very difficult for companies to distinguish themselves in the market and gain new customers. In addition to competitors, many businesses are deciding to design their own websites and execute online advertising campaigns themselves, reducing the number of potential customers. There are a large number of 23 companies that provide website templates that a business can purchase and change easily, without the need to hire a web development company. While basic coding knowledge is needed to effectively customize a template to fit an individual business’s needs, many new businesses are choosing to use an existing template versus paying for a new website design. Our Business Description of Business Liberty Vision is a full service web design and online marketing agency. We provide services such as web design and development and online marketing solutions that enable small businesses to build and maintain an effective online presence. To date, we have focused on providing one-off services such as development of a fully functioning website to small business clients. We plan to expand our service offerings to include subscription-based service packages. Our current services include: Website Development and Consulting Website Design Services We design websites to suit small business needs, whether it’s a fully interactive flash-driven site or a simple informational page. Our custom design service includes the development of a unique website look and layout that is created specifically for our client. Website Usability Consulting Through our website usability consulting services, we help our customers ensure that their website is as intuitive and easy to use as possible for their visitors. Areas we consult on include design and layout, information architecture, ease of navigation, functionality, accessibility, content and search engine optimization requirements. Website Maintenance Keeping a website up to date is crucial to ensure effective communication with the website visitors and clients of the business. It also improves the website's search engine optimization if the content is being updated on a regular basis. Web Analytics Implementation It is essential to know who is coming to a website, where they are coming from, what keywords they are using to find the site, and what they are interested in once they have arrived. Liberty Vision helps with implementation of Google Analytics, a web statistics package that provides all this information. Web Marketing Paid Search Advertising Paid search advertising refers to search engine advertising such as Google AdWords (Yahoo and MSN have similar paid search programs available).Search advertisements are targeted to match key search terms (called keywords) entered on search engines. We help our clients manage their search campaigns by: ·Selecting targeted keywords and monitoring their effectiveness. ·Creating relevant ad text that is likely to convert leads into new clients. ·Structuring and optimizing campaigns for better performance and maximum results. 24 ·Providing monthly client reporting to communicate the strategies we’ve implemented and recommendations for future improvement. ·Developing and researching possible new avenues of online marketing to build the new client base. Online Marketing Review We provide feedback and recommendations on how to improve areas such as: website design and layout, information architecture, ease of navigation, functionality, accessibility, content and search engine optimization requirements. Landing Page Development There are times when an advertising campaign needs to send users to a specific 'landing page' on a website as opposed to the homepage or another general site page. We assist with landing page development which is a must have for any sort of paid search advertising. Blogging A blog is an efficient way to improve search engine optimization while encouraging repeat visitors and increasing visitor retention. We can implement a customized blog that blends seamlessly into the design of an existing website. Social & Viral Marketing Social and Viral Marketing Campaigns We help companies to create innovative, interactive online campaigns that build brand awareness. Social Media Consulting We provide consulting services on social media outlet management, such as corporate Facebook pages and Twitter account updates. Custom Facebook Page Design We help ensure that the company’s presence on Facebook reflects the look and feel of the company's brand and website. Twitter Maintaining and managing an active and effective Twitter account requires regular attention. Our twitter management services include: monitoring the account and Twitter in general, responding to specific comments from followers, responding to general comments related to our client’s business and adding new followers. Search Engine Optimization (SEO) Consulting Keyword Strategy Proper keyword selection is the foundation of any good search engine effort. We run predictive queries to determine the level of search traffic and go after terms that have sufficient search volume. Potential for conversion is evaluated against the level of search traffic. Our goal is to get the site high quality traffic, not just quantity. We evaluate the competitiveness of the keywords to be targeted. The level of competitiveness of our client’s keywords helps us to evaluate which In-page and Off- page strategies that will be necessary to get results. 25 In-page Strategy We review the website to implement changes that are required for the site to rank well for the terms identified in the Keyword Strategy. We examine what impediments are preventing search engine spiders from crawling the site and how they can be rectified. Content Strategy / Authority Building: Quality content is one of the fundamental keys to attracting relevant quality links from other sites, and therefore in securing superior search engine rankings. Quality content is the only strategy condoned by Google, Yahoo, and Bing. With the advent of Universal Search, many types of content now exist, and provide opportunities to rank. Some opportunities are: a. textual content b. images/picture c. videos d. user ratings and reviews e. widgets and calculators f. user generated content g. press releases/news h. location on a map (Google Local) When done properly, content is not only distinctive, but can position the author as an authority in his/her space. Being viewed as an authority has many advantages, including the attraction of many more opportunities related to quality relevant links. Plan of Operations We expect to complete our offering within three to six months from the effective date of our registration statement. To date, we have focused on providing individualized services to clients on a contract basis. Our plan over the next twelve months is to expand our client base, to develop a suite of subscription-based services that will allow us to generate a steady stream of revenue and to incorporate online ad management services to our services offered. We plan to develop a suite of subscription-based services to offer to our existing clients and to new customers starting in the fourth quarter of 2011. The scope of services offered will depend on the amount raised through this offering. If we raise the minimum amount, we plan to develop and offer the following services: a)Website Optimization Monthly Package. In order to receive the most effective results from website optimization, SEO solutions should be implemented and refined on an ongoing basis. Regular optimization efforts are very important, as search engines are known for revising their algorithms. We plan to offer 3-4 different packages of monthly website optimization services, based on service hours provided. The allotment of hours may be used towards solutions such as keyword research, SEO copywriting, optimized website coding, naming strategy improvements, internal link building or inbound link building. We expect to spend approximately $2,500 to develop this service. 26 b)Ad Serving and Management. Our customers may want to serve online ads on their website, or may need to implement a Pay Per Click advertising campaign to advertise their goods and services. We plan to develop a range of services to address both publishers’ (websites that serve ads from ad networks) and advertisers’ needs. By purchasing a monthly subscription package, a Liberty Vision client will get custom designed ads, whether text-only or graphic banners, management, scheduling and prioritizing of their ads, and implementation with online ad serving solutions such as Google DoubleClick for Publishers or Google Adwords. We expect to spend approximately $30,000 to develop this range of services. If we do not sell the minimum amount of shares, we will be forced to indefinitely postpone the development and launch of these services. If we raise the maximum amount, we plan to develop and offer the Website Optimization Monthly Package and Ad Serving and Management services, as well as, hire a full-time web developer and a part-time graphic designer. We expect these hires to cost approximately $120,000 per year. All future hiring will be subject to financing and sufficient cash flow from operations. If we raise the minimum amount of proceeds from this offering we may not be able to hire additional employees. Additionally, we plan to develop a suite of services that will allow a customer to design, build and publish their own website using a simple interface that does not require any knowledge of HTML coding. We expect to spend approximately $300,000 on this project and launch it within 2 years of completion of the offering, if we raise the maximum amount. The project will consist of a standalone website that will feature monthly subscription-based websites that the user can create, edit and publish using a simple intuitive interface. Long-term Plan of Operations Our long-term, five-year plan is to expand our client base, introduce new services subject to financing and sufficient cash flow from operations, and continue marketing our services to potential clients. There is no assurance we will be successful in completing our short-term plan of operations or achieving profitable operations necessary to implement our long-term plan. Financing We intend to raise a minimum of $50,000 and up to a maximum of $500,000 of gross proceeds from this Offering.  Management believes that if we raise the minimum amount we will have sufficient cash flow to implement our short-term business plan and to meet our capital requirements for at least the next 12 months.  Management expects to keep operating costs to a minimum until cash is available through financing or operating activities.  If we are unable to generate profits or unable to obtain additional funds for our working capital needs, we may need to cease or curtail operations.   Description of Property We do not hold ownership or leasehold interest in any property. DIRECTORS, EXECUTIVE OFFICERS AND CONTROL PERSONS Our executive officers and Directors and their respective ages as of the date of this Prospectus are as follows: 27       Name ● Efficiently delivers and maintains nutrition ● Increases moisture  ● Easy to use

Age

Position 34 Stability of Ingredients The benefits of obtaining ultra purified fermented collagen that is not heat treated, and using a hydraulic pressure reaching 14,500 psi (100 MPa) during the liquefying process, prevents the destruction and changes in the properties of the active ingredients. Processing Bacillus Licheniformis                                    Pepsin Bacillus Amyloloquefaciens 35 In House Results at Beautee Collegen Research Lab in Korea Age: 26 Body part: legs Period used: 6 days Pregnancy: 2013 Stretch marks become pale   Age: 26                                                                                                                               Stretch marks become pale Body part: armpit  Period used: 6 days Pregnancy: 2013     36 Age: 27                                                                                                              Improved appearance of stretch mark Body part: abdomen Period used: 3 weeks (6 times/week) 8 months pregnant Clinical Results in Beijing   37 Biomark Bio-Medical Products: The primary Bio-Medical Products include the following Bone-Induction Artificial Bone (BIAB) products and Vacuum Sealing Drainage (VSD) products: Product List  Oleg Gabidulin Name Description VSD 1 Negative pressure drainage special bolster VSD 2 Negative pressure drainage special bolster VSD 3 Medical Operation Film VSD 4 Medical Operation Film VSD 5 Negative pressure drainage device VSD 6 Negative pressure drainage device Bone induction Artificial bone A1 Bone induction to tissue regeneration membrane Artificial bone A1 Artificial bone to tissue regeneration membrane Bone induction Artificial bone A2 Bone induction to albumin layer Artificial bone A2 Artificial bone to collagen layer Bone induction Artificial bone A3 Bone induction to regeneration microporous membrane Artificial bone A3 Artificial bone to regeneration microporous membrane Bone induction Artificial bone A4 Bone induction to microporous albumin layer Artificial bone A4 Artificial bone to microporous albumin layer Xishu Qing Gynecological antibacterial care dressing Microcyn Skin and Wound Hydrogel Gel dressing Incision protection sleeve Incision protection sleeve Kangfu Shengyuan Collagen antimicrobial dressing I. Bone-Induction Artificial Bone BIAB has completed over 200 animal tests, 5000 clinical trial tests, and was approved by the China Food and Drug Administration of China ("CFDA") in 2006. The BIAB won the second prize of the 2007 National Natural Science Foundation of China. Vacuum Sealing Drainage (VSD) also has been approved by CFDA in 2006. 38 BIAB is a bionic porous bone repairing material, which is made of calcium phosphate through a special process. Its composition and structure is similar to the natural mineral of human bone, which accounts for its predominant bio-compatibility, biological activity and biological safety. It helps to absorb a human's own BMP growth factor; it also regulates gene function to induce bone regeneration, shortens convalescence, and achieves the goal of repairing bone defects permanently. The advanced artificial bone is used: (i) in repairing traumaticbone defects; (ii) in repairing bone defects after complete removal of bone tissue as required in the treatment of certain diseases including bone tumor, bone tuberculosis, chronic osteomyelitis, osteofibrous dysplasia, delayed union, nonunion, and false joint fracture; (iii) for treatment of bone loss orbone defects caused by congenital malformation; (iv) as a filling material for spinal fusion, joint fusion, and orthopedicbone grafting; and (v) as a filling material for bone grafting fusion and decompressive laminectomy. Product Characteristics: The BIAB provides a three-dimensional support structure and a physical and chemical composition similar to the body's naturalbonemineral. They resemble the human body's environment. It can help lead the fibrous tissue and bone marrow stromal stem cells to grow into the porous substance of the material, thus obtaining the essential multipotent mesenchymal cells for bone formation and supports the growth of cells. The human body'sfluids contain BMPand othergrowth factors,but thecontent is too low, and is insufficient topromote the occurrence of induction. The specificcomposition and structure of BIAB provides the growth factor at the binding sites. The material implanted can selectively enrich and adsorb the bone growth factors in the blood and fluid of the human body. Theintroduction of the growth factors in the microenvironment will inducemesenchymalcells to the osteoblasts differentiation andnew bone growththreshold. Under thesynergistic effect of boneinduction ofsignaling molecules andbiologicalenvironment, BIAB can promote bone gene up-regulation,enhance down-stream gene function, and regulate cell movement in thedirection of bonedifferentiation. As the cellsand nutrients transfer through the porousstructure, the BMPgrowth factors cause the formation and maturation of new bone within the Bone-Induction Artificial Bone. The implantedmaterials are thus gradually replaced with new bone, and the newbone completes growth andossification. This innovative material provides several benefits: 1.        Optimizes bone conduction performance  2.        Precise osteo-induction  3.        Rapid bone formation  4.        Suitable biodegradationabsorption andossification 5.        Long-term safety of implantation. Comparison with other products Category Advantage and Disadvantage Autogenous bone graft material l Bone conduction and bone induction property l No immunological rejection l May damage healthy tissue, cause secondary vulnus to patients l Source of bone is limited; operation lasts longer, higher risk of intra-operative bleeding and infection l May cause injury and pain around the bone Allogenic bone transplantation material and Xenogeneic bone transplantation material l Only bone conduction property, no bone induction property l Limited Source l Potential of immunological rejection and spreading of underlying diseases l May cause overreaction with large numbers of applications

39

49

Traditional artificial synthetic material	l Good biocompatibility and bone conduction property l No bone induction; absorptivity does not match the speed of bone growth l Only for filing material, not for bone tissue regeneration
External growth factor and bone matrix removal protein	l Bone induction l External source l No mechanical strength, need support material in practices l Potential risk of immunological rejection and spreading of underlying diseases l High requirements for storage and transportation l Not fully mature technology
BioMark's Bone-induction artificial bone	l Both bone conduction and safe bone induction properties Replicates normal process of osteogenesis and bone formation l Sufficient and safe sources l Avoids immunological rejection and spreading of underlying diseases, is an ideal material for repairing bone

Comparison with similar products

	Biological safety	Absorption	Bone induction
HA Silicate	+	-	-
ß-TCP Caso4	+	Too fast	-
Allogeneic bone	-	+	-
Allogeneic bone + BMP/DBM		+	+
BioMark's Bone-induction artificial bone	+	Moderate	+

II. Vacuum Sealing Drainage

VSD was approved by the CFDA in 2006. It is made of polyvinyl alcoholaqueousgelatin foam: a three-dimensional porous structure, which is non ciliated, and exhibits strong water absorption characteristics. It is hydrophilic and has excellent thermal insulation capabilities as compared with other vacuum sealing drainage specialty foams. VSD has good histocompatibility and will not adhere to a wound. VSD aids skin creation around a wound bed with minimal vulnus.The dressing material acts as a drug carrier with strong bactericidal characteristics, and the gelatin protein promotes the growth of granulation, accelerating wound healing. It can be used in the surgery of burns, orthopedics, trauma repair, plastic, and general surgery. 

40

Product Characteristics:

Advantages:

1.	Good treatment effect. VSD allows an individualized complete treatment plan, which fully ensures the effect of clinical treatment. VSD basically eliminates adverse events such as clinical wound blowing and drainage tube blocking, leading to excellent treatment reliability;
2.	Easy to operate. Using VSD is as simple as changing a fresh dressing for the wound; the material does not adhere with the wound, which avoids secondary vulnus;
3.	Large range of indications; innovation of operation, especially for large size wound treatments.

Comparison with previous technology

Category	Using Method	Requirements for the surrounding skin	Product properties	Clinical effect	Adverse events happening %	Indication
Old technology	Need certain conditions, experience and technology. Difficult to seal the wound; Long operation time; Large amount of nursing work	High	Single function; Cannot clean the wound	Common	Drainage tube blocking >70% Wound blowing 100% Material becomes dry and hard >90%	Suitable for in- patients
BioMark's VSD technology	No certain conditions, experience and technology required. Easy to seal the wound; Low operation time; Low amount of nursing work	No special requirements.	Functions of wound cleaning and vacuuming	Good	All very seldom	Suitable for out-patient and in-patient

Comparison with other products

President, Chief Executive Officer, Director

Category	Working principals	Method of use	Products properties	Clinical Effect	Adverse events happening %
BioMark's VSD Products	Cleaning the wound through the inlay drainage tube which transmits the vacuum	Easy	Functions of wound cleaning and vacuuming	Good	Very seldom
Other VSD/VAC with suckers	Drainage tube is connected with the foam material through the suckers. Transmitting vacuum effect is poor. Draining effect is poor. Potential problem for drainage tube blocking.	Need to open the sealing membrane to clean the suckers. Hard to use the suckers with the different sizes of wounds.	Single function	Poor	Very highdrainage tube blocking happens up to 70% of the time after a 3 day usage.

III. Cancer Detection Scanning Technology

The Company is also licensed to conduct research and development of BioMark's cancer detection scanning technology. The technology uses biomarkers for the early detection of cancers. In the event that the research and development of BioMark's cancer detection scanning technology provides marketable technology, the Company shall have the right of first refusal to a license to market, sell and distribute such cancer detection scanning technology.

BioMark's cancer detection scanning technology provides innovative techniques and assay analysis to increases early detection of tumors in the latent growth phase.

Poor prognosis associated with late diagnosis = large tumor size

The graph above indicates the current limit of clinical detection for most tumors. A good 70% of the natural history of the tumor has already existed by time it is detected.

Facts About Cancer from the Cancer Research UK

(http://www.cancerresearchuk.org)

	·	The leading cause of premature mortality.
	·	1 in 3 individuals will develop cancer.
	·	60 % of those will die as a result of the disease.
	·	8.2 million deaths a year or 22,000 per day.
	·	Poor prognosis due to poor therapy and, poor detection.

Cancer Prevalence

CANCER SITE		NEW CASES
Lung and Bronchus		1.6 million
Colon and Rectum		1.12 million
Stomach		1.1 million
Esophagus		0.56 million
Liver		0.7 million
Breast		1.6 million
Prostrate		0.8 million
Cervix		0.6 million
Vadim Erofeev	54	Treasurer, Chief Financial Officer, Director
Marina Sherbatenko	49	Secretary, Director
Ilia Burakov	23	Director